On Friday, the Centers for Disease Control and Prevention’s vaccine panel voted eight to three in favor of abandoning the universal recommendation of vaccinating newborns for hepatitis B, a dramatic ...

The move sparked outrage from local medical experts and lawmakers. Many soldiers at Army commands in SA likely moving to Fort Bragg Threats, dysfunction and flying: Why quitting is all the rage in DC ...

A comprehensive review of hepatitis B vaccination found no evidence that delaying the birth dose provides any safety or efficacy benefits and identified substantial risks associated with changing long ...

The CDC's Advisory Committee on Immunization Practices (ACIP) will meet Dec. 4 and 5, according to a Federal Register notice that indicates that recommendation votes may be scheduled for hepatitis B ...

SAN FRANCISCO, November 03, 2025--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy ...

The ACIP is scheduled to discuss the hepatitis B vaccine recommended at birth. Ahead of a key meeting amongst the Centers for Disease Control and Prevention (CDC) vaccine advisors -- now with 12 ...

Sen. Bill Cassidy (R-La.) warned of the risk of hepatitis B infection in infants on Wednesday, ahead of a meeting of a federal vaccine advisory panel during which changes to the current immunization ...

Eric Boodman focuses on narrative features, exploring the startling ways that science and medicine affect people’s lives. You can reach Eric on Signal at eboodman.88. It was the late 1980s and the ...

Liver specialist Maurizio Bonacini is in the race for a cure for hepatitis B, one of the world’s most widespread diseases and a top cause of liver cancer around the globe. “It’s the last frontier,” ...

A highly contagious liver infection is surging among groups who are not typically at risk. At least seven people have died. By Emily Baumgaertner Nunn Public health officials in Los Angeles County ...

Hepatitis B is a liver infection that inflames the organ and impacts its ability to function. It can be either acute (short-term) or chronic (long-term), and is estimated to impact between 880,000 and ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential functional cure for the infectious disease. On a media call Wednesday morning to ...